Fundamental Analysis
74 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +30.6% | +35.9% | 3 / 3 | +24.3% | +2.26 pp | +0.40 pp | +10.9% | 0.62 | 6.58 | 278 | +24,3% | 23,2 | +30,6% | 6.58 | 11.46 | −42,5% |
| Pts | 8 | 8 | 12 | 12 | 8 | 8 | 0 | 12 | 12 | |||||||
Valuation annotation:Price: 9.500 (close price on 2026-10-15)EPS (TTM): 1.443
Financial charts
1.Revenue & growth
VND bn278Q2/26
1.Revenue & growth
VND bn278Q2/26
2.Profit & growth
VND bn24,4Q2/26
3.Profit mix (Penman)
VND bn92,6Q2/26
4.Margins & cost structure
%20.3%Q2/26
5.Returns & cash cycle
% · days8.8%Q2/26
6.Earnings quality & cash
VND bn473Q2/26
7.Asset structure
VND bn1.345Q2/26
8.Funding & debt health
VND bn · times1.345Q2/26
9.Revenue backlog
VND bn0,54Q2/26
10.Valuation
times · %6,5×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %480Q2/26
Adjusted EPS growth, latest quarter
37.5%
Average adjusted EPS growth, 3 quarters
38.2%
Quarters at 25%+ growth
2/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26